NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054072

Registered date:05/04/2024

Combination therapy with cryoablation and radiofrequency ablation for lung cancer

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedPrimary lung cancer and metastatic lung cancer
Date of first enrollment2024/04/05
Target sample size500
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)For lung cancer, after cryoablation, the cryoablation probe is replaced by radiofrequency probe, followed by cryoablation.

Outcome(s)

Primary OutcomeLocal control rate and survival rate more than 3 years after the treatment
Secondary OutcomeShort- and long-term complications after treatment

Key inclusion & exclusion criteria

Age minimum10years-old
Age maximum100years-old
GenderMale and Female
Include criteria
Exclude criteria1. Severe pulmonary failure. 2. Life expectancy is predicted to be less than 6 months. 3. Active interstitial pneumonia.

Related Information

Contact

public contact
Name Hiroaki Nomori
Address Shikoda 617, Kashiwa city, Chiba prefecture Japan 277-8551
Telephone 0471451111
E-mail hnomori@qk9.so-net.ne.jp
Affiliation Kashiwa Kousei General Hospital Department of thoracic surgery
scientific contact
Name Hiroaki Nomori
Address Shikoda 617, Kashiwa-city, Chiba prefecture
Telephone +81471451111
E-mail hnomori@qk9.so-net.ne.jp
Affiliation Kashiwa Kousei General Hospital Department of thoracic surgery